Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

The Lancet

Volumn 395, Issue 10242, 2020, Pages 1973-1987

  Chu, Derek K ^a,b,e   Akl, Elie A ^a,c,e   Duda, Stephanie ^a,e   Solo, Karla ^a,e   Yaacoub, Sally ^c,e   Schünemann, Holger J ^a,d,e   El harakeh, Amena ^e   Bognanni, Antonio ^e   Lotfi, Tamara ^e   Loeb, Mark ^e   Hajizadeh, Anisa ^e   Bak, Anna ^e   Izcovich, Ariel ^e   Cuello Garcia, Carlos A ^e   Chen, Chen ^e   Harris, David J ^e   Borowiack, Ewa ^e   Chamseddine, Fatimah ^e   Schünemann, Finn ^e   Morgano, Gian Paolo ^e   Muti Schünemann, Giovanna E U ^e   Chen, Guang ^e   Zhao, Hong ^e   Neumann, Ignacio ^e   Chan, Jeffrey ^e   Khabsa, Joanne ^e   Hneiny, Layal ^e   Harrison, Leila ^e   Smith, Maureen ^e   Rizk, Nesrine ^e   Giorgi Rossi, Paolo ^e   AbiHanna, Pierre ^e   El khoury, Rayane ^e   Stalteri, Rosa ^e   Baldeh, Tejan ^e   Piggott, Thomas ^e   Zhang, Yuan ^e   Saad, Zahra ^e   Khamis, Assem ^e   Reinap, Marge ^e   more..

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d MDCL 3111   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTRIBUTABLE RISK; BETACORONAVIRUS; COMMUNICATION BARRIER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; DEMOGRAPHY; EYE PROTECTION; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MIDDLE EAST RESPIRATORY SYNDROME; NONHUMAN; OBSERVATIONAL STUDY; ODDS RATIO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SOCIAL DISTANCE; VIRUS TRANSMISSION; COMMUNICABLE DISEASE CONTROL; CORONAVIRUS INFECTION; EYE PROTECTIVE DEVICE; MASK; META ANALYSIS; PANDEMIC; SOCIAL ISOLATION; VIRUS PNEUMONIA;

BETACORONAVIRUS; COMMUNICABLE DISEASE CONTROL; CORONAVIRUS INFECTIONS; EYE PROTECTIVE DEVICES; HUMANS; MASKS; PANDEMICS; PNEUMONIA, VIRAL; SOCIAL DISTANCE; SOCIAL ISOLATION;

EID: 85086678484     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(20)31142-9     Document Type: Article

References (87)

1. Worldometer. COVID-19 coronavirus pandemic. https://www.worldometers.info/coronavirus/, 2020. (Accessed 28 May 2020)
2. Guo, ZD, Wang, ZY, Zhang, SF, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis, 2020 published online April 10. DOI:10.3201/eid2607.200885.
3. Chia, PY, Coleman, KK, Tan, YK, et al. Detection of air and surface contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in hospital rooms of infected patients. medRxiv, 2020 published online April 9. DOI: 10.1101/2020.03.29.20046557 (preprint).
4. Santarpia, JL, Rivera, DN, Herrera, V, et al. Transmission potential of SARS-CoV-2 in viral shedding observed at the University of Nebraska Medical Center. medRxiv, 2020 published online March 26. DOI: 10.1101/2020.03.23.20039446 (preprint).
5. Cheng, V, Wong, S-C, Chen, J, et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol 41 (2020), 493–498.
6. Wong, SCY, Kwong, RT-S, Wu, TC, et al. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect 105 (2020), 119–127.
7. Faridi, S, Niazi, S, Sadeghi, K, et al. A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran. Sci Total Environ, 725, 2020, 138401.
8. Ong, SWX, Tan, YK, Chia, PY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 323 (2020), 1610–1612.
9. Qualls, N, Levitt, A, Kanade, N, et al. Community mitigation guidelines to prevent pandemic influenza: United States, 2017. MMWR Recomm Rep 66 (2017), 1–34.
10. Feng, S, Shen, C, Xia, N, Song, W, Fan, M, Cowling, BJ, Rational use of face masks in the COVID-19 pandemic. Lancet Respir Med 8 (2020), 434–436.
11. MacIntyre, R, Chughtai, A, Tham, CD, Seale, H, COVID-19: should cloth masks be used by healthcare workers as a last resort?. https://blogs.bmj.com/bmj/2020/04/09/covid-19-should-cloth-masks-be-used-by-healthcare-workers-as-a-last-resort/, April 9, 2020. (Accessed 12 May 2020)
12. Loeb, M, Dafoe, N, Mahony, J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 302 (2009), 1865–1871.
13. Bartoszko, JJ, Farooqi, MAM, Alhazzani, W, Loeb, M, Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: a systematic review and meta-analysis of randomized trials. Influenza Other Respir Viruses, 2020 published online April 4. DOI:10.1111/irv.12745.
14. Schünemann, HJ, Moja, L, Reviews: rapid! Rapid! Rapid! … and systematic. Syst Rev, 4, 2015, 4.
15. Cochrane Training. Cochrane handbook for systematic reviews of interventions, version 6. https://training.cochrane.org/handbook/current, 2019. (Accessed 12 May 2020)
16. Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
17. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62 (2009), 1006–1012.
18. Stroup, DF, Berlin, JA, Morton, SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283 (2000), 2008–2012.
19. Jefferson, T, Del Mar, CB, Dooley, L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev, 7, 2011, CD006207.
20. Offeddu, V, Yung, CF, Low, MSF, Tam, CC, Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis. Clin Infect Dis 65 (2017), 1934–1942.
21. Guyatt, GH, Oxman, AD, Kunz, R, et al. GRADE guidelines, 7: rating the quality of evidence—inconsistency. J Clin Epidemiol 64 (2011), 1294–1302.
22. Iorio, A, Spencer, FA, Falavigna, M, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ, 350, 2015, h870.
23. Moskalewicz, A, Oremus, M, No clear choice between Newcastle-Ottawa Scale and Appraisal Tool for Cross-Sectional Studies to assess methodological quality in cross-sectional studies of health-related quality of life and breast cancer. J Clin Epidemiol 120 (2020), 94–103.
24. Wells, GA, Shea, B, O'Connell, D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp, 2019. (Accessed 12 May 2020)
25. Sterne, JAC, Savović, J, Page, MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, 2019, l4898.
26. Guyatt, G, Oxman, AD, Akl, EA, et al. GRADE guidelines, 1: introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64 (2011), 383–394.
27. Guyatt, GH, Thorlund, K, Oxman, AD, et al. GRADE guidelines, 13: preparing summary of findings tables and evidence profiles—continuous outcomes. J Clin Epidemiol 66 (2013), 173–183.
28. Santesso, N, Carrasco-Labra, A, Langendam, M, et al. Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments. J Clin Epidemiol 74 (2016), 28–39.
29. Santesso, N, Glenton, C, Dahm, P, et al. GRADE guidelines, 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol 119 (2020), 126–135.
30. Higgins, JP, Thompson, SG, Controlling the risk of spurious findings from meta-regression. Stat Med 23 (2004), 1663–1682.
31. Jefferson, T, Jones, M, Al Ansari, LA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses, part 1: face masks, eye protection and person distancing—systematic review and meta-analysis. medRxiv, 2020 published online April 7. DOI: 10.1101/2020.03.30.20047217 (preprint).
32. Sutton, AJ, Abrams, KR, Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res 10 (2001), 277–303.
33. Goligher, EC, Tomlinson, G, Hajage, D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA 320 (2018), 2251–2259.
34. Alraddadi, BM, Al-Salmi, HS, Jacobs-Slifka, K, et al. Risk factors for Middle East respiratory syndrome coronavirus infection among healthcare personnel. Emerg Infect Dis 22 (2016), 1915–1920.
35. Arwady, MA, Alraddadi, B, Basler, C, et al. Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014. Emerg Infect Dis 22 (2016), 1395–1402.
36. Bai, Y, Wang, X, Huang, Q, et al. SARS-CoV-2 infection in health care workers: a retrospective analysis and a model study. medRxiv, 2020 published online April 1. DOI: 10.1101/2020.03.29.20047159 (preprint).
37. Burke, RM, Balter, S, Barnes, E, et al. Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States. medRxiv, 2020 published online May 3. DOI: 10.1101/2020.04.27.20081901 (preprint).
38. Caputo, KM, Byrick, R, Chapman, MG, Orser, BJ, Orser, BA, Intubation of SARS patients: infection and perspectives of healthcare workers. Can J Anaesth 53 (2006), 122–129.
39. Chen, WQ, Ling, WH, Lu, CY, et al. Which preventive measures might protect health care workers from SARS?. BMC Public Health, 9, 2009, 81.
40. Cheng, H-Y, Jian, S-W, Liu, D-P, Ng, T-C, Huang, W-T, Lin, H-H, High transmissibility of COVID-19 near symptom onset. medRxiv, 2020 published online March 19. DOI: 10.1101/2020.03.18.20034561 (preprint).
41. Wang, X, Pan, Z, Cheng, Z, Association between 2019-nCoV transmission and N95 respirator use. J Hosp Infect 105 (2020), 104–105.
42. Ha, LD, Bloom, SA, Hien, NQ, et al. Lack of SARS transmission among public hospital workers, Vietnam. Emerg Infect Dis 10 (2004), 265–268.
43. Hall, AJ, Tokars, JI, Badreddine, SA, et al. Health care worker contact with MERS patient, Saudi Arabia. Emerg Infect Dis 20 (2014), 2148–2151.
44. Heinzerling, A, Stuckey, MJ, Scheuer, T, et al. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient: Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep 69 (2020), 472–476.
45. Ho, KY, Singh, KS, Habib, AG, et al. Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. J Infect Dis 189 (2004), 642–647.
46. Van Kerkhove, MD, Alaswad, S, Assiri, A, et al. Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015. Emerg Infect Dis J 25 (2019), 1802–1809.
47. Ki, HK, Han, SK, Son, JS, Park, SO, Risk of transmission via medical employees and importance of routine infection-prevention policy in a nosocomial outbreak of Middle East respiratory syndrome (MERS): a descriptive analysis from a tertiary care hospital in South Korea. BMC Pulm Med, 19, 2019, 190.
48. Kim, T, Jung, J, Kim, SM, et al. Transmission among healthcare worker contacts with a Middle East respiratory syndrome patient in a single Korean centre. Clin Microbiol Infect 22 (2016), e11–e13.
49. Kim, CJ, Choi, WS, Jung, Y, et al. Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity. Clin Microbiol Infect 22 (2016), 880–886.
50. Lau, JTF, Lau, M, Kim, JH, Tsui, HY, Tsang, T, Wong, TW, Probable secondary infections in households of SARS patients in Hong Kong. Emerg Infect Dis 10 (2004), 235–243.
51. Liu, W, Tang, F, Fang, LQ, et al. Risk factors for SARS infection among hospital healthcare workers in Beijing: a case control study. Trop Med Int Health 14:suppl 1 (2009), 52–59.
52. Liu, ZQ, Ye, Y, Zhang, H, Guohong, X, Yang, J, Wang, JL, Analysis of the spatio-temporal characteristics and transmission path of COVID-19 cluster cases in Zhuhai. Trop Geogr, 2020 published online March 12. DOI:10.13284/j.cnki.rddl.003228.
53. Loeb, M, McGeer, A, Henry, B, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis 10 (2004), 251–255.
54. Ma, HJ, Wang, HW, Fang, LQ, et al. A case-control study on the risk factors of severe acute respiratory syndromes among health care workers. Zhonghua Liu Xing Bing Xue Za Zhi 25 (2004), 741–744 (in Chinese).
55. Nishiura, H, Kuratsuji, T, Quy, T, et al. Rapid awareness and transmission of severe acute respiratory syndrome in Hanoi French Hospital, Vietnam. Am J Trop Med Hyg 73 (2005), 17–25.
56. Nishiyama, A, Wakasugi, N, Kirikae, T, et al. Risk factors for SARS infection within hospitals in Hanoi, Vietnam. Jpn J Infect Dis 61 (2008), 388–390.
57. Olsen, SJ, Chang, HL, Cheung, TY, et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 349 (2003), 2416–2422.
58. Park, BJ, Peck, AJ, Kuehnert, MJ, et al. Lack of SARS transmission among healthcare workers, United States. Emerg Infect Dis 10 (2004), 244–248.
59. Park, JY, Kim, BJ, Chung, KH, Hwang, YI, Factors associated with transmission of Middle East respiratory syndrome among Korean healthcare workers: infection control via extended healthcare contact management in a secondary outbreak hospital. Respirology, 21(suppl 3), 2016, 89 (abstr APSR6-0642).
60. Peck, AJ, Newbern, EC, Feikin, DR, et al. Lack of SARS transmission and U.S. SARS case-patient. Emerg Infect Dis 10 (2004), 217–224.
61. Pei, LY, Gao, ZC, Yang, Z, et al. Investigation of the influencing factors on severe acute respiratory syndrome among health care workers. Beijing Da Xue Xue Bao Yi Xue Ban 38 (2006), 271–275.
62. Rea, E, Laflèche, J, Stalker, S, et al. Duration and distance of exposure are important predictors of transmission among community contacts of Ontario SARS cases. Epidemiol Infect 135 (2007), 914–921.
63. Reuss, A, Litterst, A, Drosten, C, et al. Contact investigation for imported case of Middle East respiratory syndrome, Germany. Emerg Infect Dis 20 (2014), 620–625.
64. Reynolds, MG, Anh, BH, Thu, VH, et al. Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi, Vietnam, 2003. BMC Public Health, 6, 2006, 207.
65. Ryu, B, Cho, SI, Oh, MD, et al. Seroprevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in public health workers responding to a MERS outbreak in Seoul, Republic of Korea, in 2015. Western Pac Surveill Response J 10 (2019), 46–48.
66. Scales, DC, Green, K, Chan, AK, et al. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 9 (2003), 1205–1210.
67. Seto, WH, Tsang, D, Yung, RWH, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 361 (2003), 1519–1520.
68. Teleman, MD, Boudville, IC, Heng, BH, Zhu, D, Leo, YS, Factors associated with transmission of severe acute respiratory syndrome among health-care workers in Singapore. Epidemiol Infect 132 (2004), 797–803.
69. Tuan, PA, Horby, P, Dinh, PN, et al. SARS transmission in Vietnam outside of the health-care setting. Epidemiol Infect 135 (2007), 392–401.
70. Wang, Q, Huang, X, Bai, Y, et al. Epidemiological characteristics of COVID-19 in medical staff members of neurosurgery departments in Hubei province: a multicentre descriptive study. medRxiv, 2020 published online April 24. DOI: 10.1101/2020.04.20.20064899 (preprint).
71. Wiboonchutikul, S, Manosuthi, W, Likanonsakul, S, et al. Lack of transmission among healthcare workers in contact with a case of Middle East respiratory syndrome coronavirus infection in Thailand. Antimicrob Resist Infect Control, 5, 2016, 21.
72. Wilder-Smith, A, Teleman, MD, Heng, BH, Earnest, A, Ling, AE, Leo, YS, Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis 11 (2005), 1142–1145.
73. Wong, TW, Lee, CK, Tam, W, et al. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis 10 (2004), 269–276.
74. Wu, J, Xu, F, Zhou, W, et al. Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis 10 (2004), 210–216.
75. Yin, WW, Gao, LD, Lin, WS, et al. Effectiveness of personal protective measures in prevention of nosocomial transmission of severe acute respiratory syndrome. Zhonghua Liu Xing Bing Xue Za Zhi 25 (2004), 18–22.
76. Yu, ITS, Wong, TW, Chiu, YL, Lee, N, Li, Y, Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients. Clin Infect Dis 40 (2005), 1237–1243.
77. Yu, IT, Xie, ZH, Tsoi, KK, et al. Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?. Clin Infect Dis 44 (2007), 1017–1025.
78. Verbeek, JH, Rajamaki, B, Ijaz, S, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev, 7, 2019, CD011621.
79. MacIntyre, CR, Wang, Q, Seale, H, et al. A randomized clinical trial of three options for N95 respirators and medical masks in health workers. Am J Respir Crit Care Med 187 (2013), 960–966.
80. Campbell, A, Chapter eight: it's not about the mask: SARS Commission final report, volume 3. http://www.archives.gov.on.ca/en/e_records/sars/report/v3-pdf/Vol3Chp8.pdf, December, 2006. (Accessed 12 May 2020)
81. Webster, P, Ontario issues final SARS Commission report. Lancet, 369, 2007, 264.
82. Rimmer, A, COVID-19: experts question guidance to reuse PPE. BMJ, 369, 2020, m1577.
83. Mackenzie, D, Reuse of N95 masks. Engineering, 2020 published online April 13. DOI:10.1016/j.eng.2020.04.003.
84. Greenhalgh, T, Schmid, MB, Czypionka, T, Bassler, D, Gruer, L, Face masks for the public during the covid-19 crisis. BMJ, 369, 2020, m1435.
85. Bahl, P, Doolan, C, de Silva, C, Chughtai, AA, Bourouiba, L, MacIntyre, CR, Airborne or droplet precautions for health workers treating coronavirus disease 2019?. J Infect Dis, 2020 published online April 16. DOI:10.1093/infdis/jiaa189.
86. Schünemann, HJ, Khabsa, J, Solo, K, et al. Ventilation techniques and risk for transmission of coronavirus disease, including COVID-19: a living systematic review of multiple streams of evidence. Ann Intern Med, 2020 published online May 22. DOI:10.7326/M20-2306.
87. Leung, NHL, Chu, DKW, Shiu, EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 26 (2020), 676–680.